SciVision Biotech Inc.(TW:1786)
NT$52.00+0.90 (+10.52%)
TW:1786
SciVision Biotech Inc. financials statements
NT$52.00
At close:+0.90 (+10.52%)
SciVision Biotech Inc. (1786) Income Statement
SciVision Biotech Inc. Income Statement
Last quarter (Q2 2026), SciVision Biotech Inc.'s total revenue was NT$211.03M, an increase of 0.73% from the same quarter last year. In Q2, SciVision Biotech Inc.'s net income was NT$34.64M. See SciVision Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 886.62M | NT$ 883.31M | NT$ 712.99M | NT$ 557.35M | NT$ 505.54M | |
| NT$ 638.39M | NT$ 655.68M | NT$ 512.49M | NT$ 371.87M | NT$ 341.84M | |
| NT$ 448.47M | NT$ 407.57M | NT$ 312.86M | NT$ 237.26M | NT$ 219.89M | |
| Depreciation and Amortization | NT$ 80.56M | NT$ 65.23M | NT$ 63.13M | NT$ 62.06M | NT$ 53.02M |
| NT$ 270.35M | NT$ 362.50M | NT$ 281.35M | NT$ 238.28M | NT$ 177.27M | |
| NT$ 189.92M | NT$ 248.11M | NT$ 199.64M | NT$ 176.23M | NT$ 124.25M | |
| NT$ -4.88M | NT$ 43.49M | NT$ 10.36M | NT$ 38.94M | NT$ -5.89M | |
| NT$ 185.04M | NT$ 291.60M | NT$ 210.00M | NT$ 173.55M | NT$ 116.06M | |
| NT$ 162.34M | NT$ 242.25M | NT$ 177.90M | NT$ 141.72M | NT$ 101.72M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.24 | NT$ 3.51 | NT$ 2.66 | NT$ 2.14 | NT$ 1.54 |
| Diluted EPS | NT$ 2.24 | NT$ 3.30 | NT$ 2.33 | NT$ 1.92 | NT$ 1.51 |
| Weighted Average Shares Outstanding | 72.47M | 69.11M | 66.88M | 66.19M | 66.19M |
| Weighted Average Shares Outstanding (Diluted) | 72.47M | 74.47M | 76.44M | 74.66M | 70.98M |
Currency in TWD
